Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/104697
Author(s): Brigida Pinho
Miguel M Santos
Anabela Fonseca Silva
Patricia Valentao
Paula B Andrade
Jorge M A Oliveira
Title: How mitochondrial dysfunction affects zebrafish development and cardiovascular function: an in vivo model for testing mitochondria-targeted drugs
Issue Date: 2013
Abstract: Background and Purpose Mitochondria are a drug target in mitochondrial dysfunction diseases and in antiparasitic chemotherapy. While zebrafish is increasingly used as a biomedical model, its potential for mitochondrial research remains relatively unexplored. Here, we perform the first systematic analysis of how mitochondrial respiratory chain inhibitors affect zebrafish development and cardiovascular function, and assess multiple quinones, including ubiquinone mimetics idebenone and decylubiquinone, and the antimalarial atovaquone. Experimental Approach Zebrafish (Danio rerio) embryos were chronically and acutely exposed to mitochondrial inhibitors and quinone analogues. Concentration-response curves, developmental and cardiovascular phenotyping were performed together with sequence analysis of inhibitor-binding mitochondrial subunits in zebrafish versus mouse, human and parasites. Phenotype rescuing was assessed in co-exposure assays. Key Results Complex I and II inhibitors induced developmental abnormalities, but their submaximal toxicity was not additive, suggesting active alternative pathways for complex III feeding. Complex III inhibitors evoked a direct normal-to-dead transition. ATP synthase inhibition arrested gastrulation. Menadione induced hypochromic anaemia when transiently present following primitive erythropoiesis. Atovaquone was over 1000-fold less lethal in zebrafish than reported for Plasmodium falciparum, and its toxicity partly rescued by the ubiquinone precursor 4-hydroxybenzoate. Idebenone and decylubiquinone delayed rotenone- but not myxothiazol- or antimycin-evoked cardiac dysfunction. Conclusion and Implications This study characterizes pharmacologically induced mitochondrial dysfunction phenotypes in zebrafish, laying the foundation for comparison with future studies addressing mitochondrial dysfunction in this model organism. It has relevant implications for interpreting zebrafish disease models linked to complex I/II inhibition. Further, it evidences zebrafish's potential for in vivo efficacy or toxicity screening of ubiquinone analogues or antiparasitic mitochondria-targeted drugs.
Subject: Medicina básica
Basic medicine
Scientific areas: Ciências médicas e da saúde::Medicina básica
Medical and Health sciences::Basic medicine
URI: https://repositorio-aberto.up.pt/handle/10216/104697
Related Information: info:eu-repo/grantAgreement/Reitoria Universidade do Porto/Reitoria Universidade do Porto/PPII_ZEBRA/Targeting mitochondrial dysfunction with epigenetic modulatory drugs: an integrated in vitro (neurons) and in vivo (zebrafish) approach/PPII_ZEBRA
info:eu-repo/grantAgreement/Reitoria Universidade do Porto/Reitoria Universidade do Porto/PPII_CARDIAC/Comparative analysis of teratogenic potential and cardiac abnormalities induced by histone deacetylase inhibitors:Predicting human health risk and environmental hazard in the zebrafish model/PPII_CARDIAC
info:eu-repo/grantAgreement/FCT - Fundação para a Ciência e Tecnologia/Operacional Factores de Competitividade/PTDC/NEU-NMC/0237/2012/Inibição de KDACs e dinâmica intracelular: impacto no desenvolvimento, sobrevivência e transmissão NEUROnal /KDAC´S
Document Type: Artigo em Revista Científica Internacional
Rights: openAccess
Appears in Collections:FCUP - Artigo em Revista Científica Internacional
FFUP - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
102383.pdfPinho Oliveira BJP3.41 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.